Original Articles |
From the Department of Biomedical Engineering (M.K.R., J.K.V., T.K.J., M.M.Y., V.L.), Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio; and the Department of Pharmaceutical Sciences (J.K.V., S.K.S., V.L.), College of Pharmacy, University of Nebraska Medical Center, Omaha, Neb.
Correspondence to Vinod Labhasetwar, PhD, Department of Biomedical Engineering/ND20, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195. E-mail labhasv{at}ccf.org
Received July 21, 2008; accepted October 24, 2008.
Background— A significant fraction of vascular smooth muscle cells (VSMCs) undergo rapid apoptosis after balloon angioplasty. In this study, we tested the hypothesis that protecting VSMCs from undergoing apoptosis prevents the cascade of events that lead to intimal hyperplasia.
Methods and Results— Rapamycin-loaded gel-like nanoparticles (mean diameter, 54±5 nm) were infused locally in a rat carotid artery model of vascular injury. The drug has both antiapoptotic and antiproliferative effects on VSMCs and hence was selected for the current study. Localized delivery of nanoparticles sustained the drug level in the target artery for >2 weeks; demonstrated significant inhibition of hyperplasia (intima/media ratio, 1.5±0.02 versus 2.7±0.6; P<0.01); and most importantly, reendothelialized the injured artery (endothelium coverage: treated 82% versus control 28%). We also demonstrated inhibition of activation of caspase-3/7 enzymes in the treated artery, preventing VSMCs from undergoing apoptosis and subsequent infiltration of macrophages.
Conclusions— It may be postulated that the localized delivery of rapamycin inhibited apoptosis of VSMCs, minimizing the inflammatory response to the injury and, thus, creating conditions conducive to vascular repair (reendothelialization). Unlike stenting, which can lead to thrombosis and increased risk for in-stent restenosis, our approach could eliminate or minimize long-term complications because the injured artery undergoes a natural process of reendothelialization.
Key Words: catheterization endothelium restenosis apoptosis nanoparticles
Related Article
|
Home | Subscriptions | Archives | Feedback | Authors | Help | Circulation Journals Home | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |